Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Sanofi India Limited ( (IN:SANOFI) ) has issued an update.
Sanofi India Limited announced the cessation of Mr. Rachid Ayari as the Interim Managing Director effective October 26, 2025. Mr. Ayari will continue as the Whole-time Director and Chief Financial Officer. The Board has appointed Mr. Deepak Arora as an Additional Director and Managing Director for a three-year term starting October 27, 2025. This leadership change is expected to impact the company’s strategic direction and operational management, with Mr. Arora authorized to determine and disclose material events to stock exchanges.
More about Sanofi India Limited
Sanofi India Limited operates in the pharmaceutical industry, focusing on the development and distribution of healthcare solutions. The company is known for its range of pharmaceutical products and services, catering to various medical needs and contributing to the healthcare sector in India.
Average Trading Volume: 1,869
Technical Sentiment Signal: Sell
Current Market Cap: 108.6B INR
Learn more about SANOFI stock on TipRanks’ Stock Analysis page.